CONTEXT: Bladder cancer diagnosis and surveillance includes cystoscopy and cytology.
The limitation of urinary cytology is its low sensitivity for low-grade recurrences. As of now …

The presence of extracellular circulating or cell-free RNA in biological fluids is becoming a
promising diagnostic tool for non invasive and cost effective cancer detection. Extracellular …

This is the first of 2 articles that summarize the findings of the International Consensus Panel
on cytology and bladder tumor markers. The objectives of our panel were to reach a …

With an estimated 74,000 new cases and 16,000 deaths for 2015, BC is the fifth most
frequent malignancy in the United States. 1 Urothelial carcinoma of the bladder (UCB) …

Bladder cancer is currently diagnosed using cystoscopy and cytology in patients with
suspicious signs and symptoms. These tests are also used to monitor patients with a history …

Telomerase activity has been measured in a wide variety of cancerous and non-cancerous
tissue types, and the vast majority of clinical studies have shown a direct correlation …

The diagnosis of both primary and recurrent bladder tumors currently relies upon the urine
cytology and cystoscopy. Neither of these diagnostic tools is completely accurate …

Background Identification of urinary biomarkers for detection of bladder cancer recurrence
would be beneficial to minimize the frequency of cystoscopy. Our objective was to determine …

Cellular senescence, the state of permanent growth arrest, is the inevitable fate of replicating
normal somatic cells. Postulated to underlie this finite replicative span is the physiology of …

Recent advances in medicine have dramatically reduced the incidence and mortality of
many cardiovascular, infectious, and certain neoplastic diseases; the overall mortality for …